Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,831,000 | 3,324,000 | 5,018,000 | 6,240,000 | 6,360,000 |
| Marketable Securities | 1,107,000 | 1,258,000 | 911,000 | 615,000 | 816,000 |
| Receivables | 5,781,000 | 5,533,000 | 4,999,000 | 7,009,000 | 7,561,000 |
| Inventories | 2,890,000 | 3,035,000 | 2,334,000 | 2,143,000 | 1,960,000 |
| Other current assets | 982,000 | 0 | 0 | 0 | 0 |
| TOTAL | $15,591,000 | $13,150,000 | $13,262,000 | $16,007,000 | $16,697,000 |
| Non-Current Assets | |||||
| PPE Net | 7,421,000 | 7,615,000 | 6,848,000 | 6,413,000 | 6,010,000 |
| Investments And Advances | 1,079,000 | 1,540,000 | 1,169,000 | 989,000 | 1,026,000 |
| Intangibles | 33,666,000 | 38,013,000 | 39,244,000 | 34,446,000 | 32,531,000 |
| Other Non-Current Assets | 2,894,000 | 3,036,000 | 2,003,000 | 2,201,000 | 2,331,000 |
| TOTAL | $45,060,000 | $50,204,000 | $49,264,000 | $44,049,000 | $41,898,000 |
| Total Assets | $60,651,000 | $63,354,000 | $62,526,000 | $60,056,000 | $58,595,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,754,000 | 2,247,000 | 2,307,000 | 916,000 | 2,446,000 |
| Accounts payable and accrued liabilities | 12,841,000 | 11,641,000 | 10,486,000 | 11,663,000 | 11,886,000 |
| Other current liabilities | 533,000 | 1,145,000 | 1,083,000 | 807,000 | 644,000 |
| TOTAL | $16,292,000 | $16,383,000 | $15,256,000 | $14,869,000 | $17,330,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,359,000 | 15,560,000 | 14,501,000 | 14,137,000 | 8,397,000 |
| aiOther Non-Current Liabilities | 9,775,000 | 10,907,000 | 12,237,000 | 9,875,000 | 11,424,000 |
| TOTAL | $30,315,000 | $30,329,000 | $30,601,000 | $26,678,000 | $21,619,000 |
| Total Liabilities | $46,607,000 | $46,712,000 | $45,857,000 | $41,547,000 | $38,949,000 |
| Shareholders' Equity | |||||
| Common Shares | 317,000 | 317,000 | 316,000 | 316,000 | 316,000 |
| Retained earnings | 5,683,000 | 8,221,000 | 8,140,000 | 11,834,000 | 13,029,000 |
| Other shareholders' equity | 3,617,000 | 3,711,000 | 3,862,000 | 2,055,000 | 2,040,000 |
| TOTAL | $14,044,000 | $16,642,000 | $16,669,000 | $18,509,000 | $19,646,000 |
| Total Liabilities And Equity | $60,651,000 | $63,354,000 | $62,526,000 | $60,056,000 | $58,595,000 |